Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications

12 Nov 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to DNA Repair Mechanisms
Share to PARP inhibition in cancer therapy

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 39533099
DOI: 10.1038/s41573-024-01060-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 18 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implicationsPMID 39533099Read ↗

DNA damage response inhibitors in cancer therapy: Mechanisms, clinical development, and combination strategiesSemantic proximity Read ↗

Targeting DNA damage response pathways in tumor drug resistance: Mechanisms, clinical implications, and future directionsSemantic proximity Read ↗

The DNA damage response and cancer therapySemantic proximity Read ↗

DNA Damage Response in Cancer Therapy and Resistance: Challenges and OpportunitiesSemantic proximity Read ↗

Inhibition of DNA Repair in Cancer Therapy: Toward a Multi-Target ApproachSemantic proximity Read ↗

Targeting DNA Repair Pathways for Cancer Treatment: what’s new?Semantic proximity Read ↗

Advances in DNA damage response inhibitors in colorectal cancer therapySemantic proximity Read ↗

Small-molecule drug repurposing to target DNA damage repair and response pathwaysSemantic proximity Read ↗

Targeting the DNA damage response for patients with lymphoma: Preclinical and clinical evidencesSemantic proximity Read ↗

DNA Damage and Its Role in Cancer Therapeutics.Semantic proximity Read ↗

Therapeutic Targeting of DNA Damage Response in CancerSemantic proximity Read ↗

Targeting DNA repair pathway in cancer: Mechanisms and clinical applicationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.